These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

926 related items for PubMed ID: 15910627

  • 21. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians.
    Brod M, Rana A, Barnett AH.
    Curr Med Res Opin; 2012 Dec; 28(12):1947-58. PubMed ID: 23150950
    [Abstract] [Full Text] [Related]

  • 22. Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium.
    Peene B, D'Hooge D, Vandebrouck T, Mathieu C.
    Acta Clin Belg; 2014 Dec; 69(6):439-45. PubMed ID: 25212241
    [Abstract] [Full Text] [Related]

  • 23. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes.
    Pedersen-Bjergaard U, Pramming S, Thorsteinsson B.
    Diabetes Metab Res Rev; 2003 Dec; 19(3):232-40. PubMed ID: 12789657
    [Abstract] [Full Text] [Related]

  • 24. Relationships between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetic patients.
    Lysy J, Israeli E, Strauss-Liviatan N, Goldin E.
    Neurogastroenterol Motil; 2006 Jun; 18(6):433-40. PubMed ID: 16700722
    [Abstract] [Full Text] [Related]

  • 25. Insulin analogues and severe hypoglycaemia in type 1 diabetes.
    Kristensen PL, Hansen LS, Jespersen MJ, Pedersen-Bjergaard U, Beck-Nielsen H, Christiansen JS, Nørgaard K, Perrild H, Parving HH, Thorsteinsson B, Tarnow L.
    Diabetes Res Clin Pract; 2012 Apr; 96(1):17-23. PubMed ID: 22136722
    [Abstract] [Full Text] [Related]

  • 26. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection.
    Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jørgensen HV, Matthews DR, Hougaard P, Thorsteinsson B.
    Diabetes Metab Res Rev; 2004 Apr; 20(6):479-86. PubMed ID: 15386817
    [Abstract] [Full Text] [Related]

  • 27. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N, Shashaj B.
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [Abstract] [Full Text] [Related]

  • 28. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L, Koenen C, Weng W, Selam JL.
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [Abstract] [Full Text] [Related]

  • 29. Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT Study.
    Kern W, Holstein A, Moenninghoff C, Kienhöfer J, Riedl M, Kulzer B.
    Exp Clin Endocrinol Diabetes; 2017 Oct; 125(9):592-597. PubMed ID: 28750429
    [Abstract] [Full Text] [Related]

  • 30. Insulin binding to antibodies is a risk factor for inexplicable severe hypoglycaemia in children with type-1 diabetes mellitus.
    Seewi O, Jaeger C, Bretzel RG, Schönau E.
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):293-7. PubMed ID: 18484562
    [Abstract] [Full Text] [Related]

  • 31. Hypoglycaemic episodes in patients with type 2 diabetes--risk factors and associations with patient-reported outcomes: The PANORAMA Study.
    Simon D, de Pablos-Velasco P, Parhofer KG, Gönder-Frederick L, Duprat Lomon I, Vandenberghe H, Eschwège E, Bradley C.
    Diabetes Metab; 2015 Dec; 41(6):470-9. PubMed ID: 26455870
    [Abstract] [Full Text] [Related]

  • 32. Risk factors of severe hypoglycaemia in adult patients with Type I diabetes--a prospective population based study.
    Mühlhauser I, Overmann H, Bender R, Bott U, Berger M.
    Diabetologia; 1998 Nov; 41(11):1274-82. PubMed ID: 9833933
    [Abstract] [Full Text] [Related]

  • 33. [Hypoglycemia--a dreaded complication of diabetes].
    Bjørgaas M.
    Tidsskr Nor Laegeforen; 2000 Aug 30; 120(20):2441-4. PubMed ID: 11475234
    [Abstract] [Full Text] [Related]

  • 34. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA, Lee LJ, Shi L, Reynolds K, Jackson JA, Fonseca V.
    Diabet Med; 2008 Aug 30; 25(8):924-32. PubMed ID: 18959605
    [Abstract] [Full Text] [Related]

  • 35. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.
    de Galan BE, Schouwenberg BJ, Tack CJ, Smits P.
    Neth J Med; 2006 Sep 30; 64(8):269-79. PubMed ID: 16990690
    [Abstract] [Full Text] [Related]

  • 36. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.
    Pedersen-Bjergaard U, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Christiansen JS, Jensen T, Hougaard P, Parving HH, Thorsteinsson B, Tarnow L.
    Lancet Diabetes Endocrinol; 2014 Jul 30; 2(7):553-61. PubMed ID: 24794703
    [Abstract] [Full Text] [Related]

  • 37. Hypoglycaemic episodes in children with insulin dependent diabetes mellitus--can the frequency or severity be reduced?
    McGovern MC, Carson D.
    Ir Med J; 2001 Feb 30; 94(2):38, 40. PubMed ID: 11321169
    [Abstract] [Full Text] [Related]

  • 38. Transferring type 2 diabetes patients with uncontrolled glycaemia from biphasic human insulin to biphasic insulin aspart 30: experiences from the PRESENT study.
    Shestakova M, Sharma SK, Almustafa M, Min KW, Ayad N, Azar ST, Danciulescu R, Khutsoane D, Guler S.
    Curr Med Res Opin; 2007 Dec 30; 23(12):3209-14. PubMed ID: 18005503
    [Abstract] [Full Text] [Related]

  • 39. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.
    Holstein A, Hammer C, Plaschke A, Ptak M, Kuhn J, Diekmann J, Kleesiek K, Egberts EH.
    Exp Clin Endocrinol Diabetes; 2004 Sep 30; 112(8):429-34. PubMed ID: 15372362
    [Abstract] [Full Text] [Related]

  • 40. Impact of therapeutic advances on hypoglycaemia in type 2 diabetes.
    Boyle PJ, Zrebiec J.
    Diabetes Metab Res Rev; 2008 Sep 30; 24(4):257-85. PubMed ID: 18232062
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.